Shiva Zaboli

机构：Gilead Sciences (United States)

发表论文 11 篇 · 总被引 33 次 · h-index 4

代表论文

• PS-150-Evidence for the presence of infectious virus in the serum from chronic hepatitis B patients suppressed on nucleos (t)ide therapy with detectable but not quantifiable HBV DNA (2019 · Journal of Hepatology · 被引 13)
• Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein (2024 · Antimicrobial Agents and Chemotherapy · 被引 6)
• Mucosal p-STAT1/3 correlates with histologic disease activity in Crohn’s disease and is responsive to filgotinib (2022 · Tissue Barriers · 被引 6)
• AB0484 Monotherapy with filgotinib, a jak1-selective inhibitor, reduces disease severity and alters immune cell subsets in the nzb/w f1 murine model of lupus (2018 · Annals of the Rheumatic Diseases · 被引 5)
• CD47 expression in solid tumors correlates with phagocytic tumor-associated macrophage gene signature (2025 · Frontiers in Immunology · 被引 2)
• 577 Non-clinical efficacy, pharmacokinetics, and pharmacodynamics of a novel bi-functional anti-CD73-TGFβRII-trap molecule in combination with immune checkpoint therapy (2021 · Regular and Young Investigator Award Abstracts · 被引 1)